Adoptive transfer of 5 × 106 PMEL T cells loaded with CD45-tethered IL-12 exhibited enhanced antitumor efficacy compared to PMEL T cells alone, both when delivered systemically by intravenous administration or when delivered directly to the tumor by intratumoral administration (fig. Here, PTPRC is linked to neoplasm.